Parameter
| Biomarker | Fatty acid pattern score | Full name | Fatty acid pattern score | Molecular Type | Lipids (fatty acids) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Metabolic Risk prediction | ||
| Disease | Metabolic Associated Fatty Liver Disease (MASLD) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Plasma phospholipids (lipidomics mass spectrometry) | ||
| Pathobiological Mechanisms | Contains 27 fatty acids, which is negatively correlated with hepatic steatosis, AUC=0.86 | ||||
| Clinical Availability Status | In the study phase, part of the cohort was used for risk prediction | ||||
| Notes and Dynamics | It can be used for MASLD risk screening in the general population and has a certain application prospect | ||||